Replays of
Money Info
Investing News Show
Money Info Airs
10 AM to 11 AM EDT
Every Tuesday
LISTEN LIVE
Use this Link To Watch The Show:
www.princetonresearch.com/money-info-live.htm
Be On The Air With Us
Call In Your Questions
888-792-1590
Money Info
The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.
The show is broadcast live on the internet and on the air from the studios of Radio Station WPSL AM 1590, Port St. Lucie, Florida — The Talk of the Treasure Coast
Money Info is hosted by investing experts Mike King, Charles Moskowitz and Gary Cella together with radio broadcasting professional Greg Wyatt.
Money Info Investment News Show Replays
June 28 Show:
June 28th Money Info Investing News show will feature live interview with:
RMS Medical Systems, Inc.
(Stock Symbol: REPR)
Chairman of the Board
Andrew Sealfon
Hear a replay of the show:
Andrew Sealfon Interview starts at 25 minutes
RMS Medical Products is a U.S. manufacturer of medical devices which maintains offices and manufacturing facilities in Chester, NY. They employ 60 people. For more than three decades, the company has been a leading innovator in the medical device industry in the development and production of proprietary devices and supplies.
Principal products include the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.
Visit the corporate website: RMSMedicalProducts.com
Click Here For REPR stock quotes,
trading charts and latest news releases
See RMS Medical Investors Information Page with financials —Click here
Fourth quarter preliminary net revenues will exceed $3.2 million, representing a slight increase over the $3.1 million of the previous quarter. Sales are led by the Company’s proprietary infusion products. The Company’s fiscal year ended February 29, 2016.
Andy Sealfon, Company President and CEO commented, “The military has expressed interest in our products for utilization in emergency applications as well as use in VA hospitals. We believe that because of our performance standards and the reliability of our products, we will provide them with great value and benefits.”
The Company manufactures medical products used for infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60(R) and the newer FreedomEdge™ Syringe Infusion Pumps, RMS Precision Flow Rate Tubing(TM) and RMS HIgH-Flo(TM) Subcutaneous Safety Needle Sets. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company’s RES-Q-VAC line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers.
NHIA is a trade association representing the interests of entities providing infusion and specialty pharmacy products and services to home-based infusion patients.
Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of 29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 thousand of net income in each of the past four years and has no debt. The patented needle sets alone can give the company a huge growth potential. In my opinion, with new products coming on stream, the stock should trade between $ 3 and $ 8 in the next two years.
Undervalued Small Cap Medical Stock News
Repro Med Systems, Inc. Posts Strong Revenue Growth,
Productivity Gains and Announces New Interim Chief Operating Officer
The Freedom60 has a proprietary technology
that makes it desirable for the
delivery of medications in a wide variety of therapies.
It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.
This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60.
Improves quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.
RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump, but can be used with any manufacturer’s infusion pump as well.
RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event of disasters where power is lost because it doesn’t require electricity.
The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles, which are considerably less painful when entering the skin.
Undervalued Medical Stock
on Investing News Show
June 21, 2016 Show:
Undervalued Skin Products Stock
Sunscreen Product Stocks
on Investment News Show
The June 21 small cap stocks to buy and investing news show, Money Info, features:
Terry Howlett,
President & CEO of
Skinvisible, Inc.
Stock Symbol: SKVI
SKINVISIBLE PHARMACEUTICALS, INC.
See Skinvisible Corporate Site — Skinvisible.com Click Here
Get Skinvisible (SKVI) stock quote, trading chart and latest news from YAHOO finance —Click Here
Listen to a Replay of the show:
The interview starts at the 24:30 Minute mark.
Once the video starts, you can hover over bottom of video to get controls and move them to the start of the interview.
Skinvisible Sunscreen product ad featured in USA Weekend edition right below Melanoma article.
Skinvisible featured in Drug Development & Delivery journal
Skinvisible’s Kintari Launches New Addition to Product Line
See News – Skinvisible Inc., through its wholly-owned subsidiary Kintari USA Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official expansion of its product line to include Kintari’s long-lasting Hand & Body Lotion.
Kintari’s product line now consists of four skincare products, all uniquely formulated utilizing our patented Invisicare® skin delivery technology and developed by scientists from Skinvisible Pharmaceuticals, Inc.
Skinvisible Pharmaceuticals is a research-and-development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time resisting both wash off and perspiration along with controlling the release of actives and reducing skin irritation. Skinvisible’s value also lies in its ability to continually generate new IP on topical products formulated with Invisicare. www.skinvisible.com, www.invisicare.com
Skin and Sunscreen Products Stocks
Skinvisible’s mission is to develop innovative technology and superior topical polymer delivery vehicles designed to significantly enhance product performance for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic and skincare products.
It is Skinvisible’s intention to direct its ongoing energies and resources towards the following objectives:
- To capitalize on licensing opportunities for its Invisicare technology and formulated products to established pharmaceutical, medical, cosmetic, skincare and consumer goods manufacturers.
- To develop new polymer delivery vehicles designed to create or enhance formulated products for existing and new customers for a variety of applications.
- To enter into strategic relationships and attract alliances to expand research, development and collaborative product investigations for its patented polymer delivery vehicles and formulations.
- To increase on-going revenues and profitability from current licensees.
- To maximize shareholder value.
Terry Howlett — President & Chief Executive Officer
Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company’s development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett’s diversified background includes senior management, marketing, and sales positions with both established and start-up companies.
Sunscreen Products Stock NEWS
Skinvisible’s Kintari Launches New Addition to Product Line
Kintari’s Skincare Line Expands
April 6, 2016 Skinvisible Inc., (SKVI) through its wholly-owned subsidiary Kintari USA Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official expansion of its product line to include Kintari’s long-lasting Hand & Body Lotion.
Kintari’s product line now consists of four skincare products, all uniquely formulated utilizing our patented Invisicare® skin delivery technology and developed by scientists from Skinvisible Pharmaceuticals, Inc.
Skinvisible Expands Its Patent Portfolio with Comprehensive Acne Patent Adapalene, Retinoic Acid, Clindamycin and OTC Actives Now with IP Protection
Skinvisible Pharmaceuticals, Inc. (SKVI) a pharmaceutical research and development company with its proprietary skin delivery technology Invisicare(R), today announced that it has expanded its patent portfolio with a new patent granted by the United States Patent and Trademark Office entitled, “ACNE TREATMENT COMPOSITION AND METHODS FOR USING.”
“This patent is an important component of Skinvisible’s comprehensive intellectual property portfolio which includes sixteen patents that provide protection in the US and major international markets up to the year 2030. The granting of this patent recognizes the unique qualities of our Invisicare delivery technology. With the acne market generating over $5 billion in the U.S. last year, this new patent further enhances the value of our pipeline of products,” said Mr. Terry Howlett, President. “We are actively seeking a partner to license and advance the clinical development of our acne formulations and other prescription dermatology products.”
Skinvisible’s Kintari Revolutionizes the Sunscreen Market Skinbrella(R) Officially Launched
Skinvisible Inc., through its wholly-owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official launch of Skinbrella(R), a patented sunscreen like no other. Skinbrella meets or exceeds all FDA requirements for a broad-spectrum, 80 minute water-resistant sunscreen.
June 14, 2016:
The June 14th show features
USA Lithium-Ion Battery Manufacturing Company
Undervalued Energy Stock News
live interview with:
Oakridge Global Energy Solutions:
The Only “Made in the USA” Lithium-Ion Battery
Steve Barber, Executive Chairman & CEO
Stock Symbol: OGES
See Corporate Site: OakG.net
See Investors Information Page with stock quotes
See Energy Stock Investors Information Report
Oakridge Global Energy Solutions, Inc. is an integrated, “made in USA”, energy storage solutions company that uses state-of-the-art technology to focus on making and developing advanced, high-quality cells, batteries, and power systems.
Their energy solutions are used in consumer, government, industrial, and military applications.
The core business is in the design, development, and manufacturing of small to large format lithium ion cells, batteries, and battery systems.
Oakridge’s strategy is to simultaneously deliver innovation and build an industrial scale platform that includes multiple lithium ion technologies and form factors that are optimized to address three target markets: stationary and grid storage; motive applications including fleet vehicles, EV and HEV; and specialty applications including Military, Aerospace, Marine, Industrial, Scientific and Telecom backup.
Oakridge’s technology team is strongly engineering driven, with core capabilities in materials, product design, process control, manufacturing technology, quality and safety.
Steve Barber: Chief Executive Officer
Steve Barber has over 30 years of experience in the international business sector with dual qualifications in science and law, specializing in international corporate finance, mergers, and acquisitions, asset acquisitions, corporate restructuring, offshore financing structures and the creation of new ventures, as well as government regulatory matters and counterterrorism risk management (especially terrorism financing restructures) in a range of international jurisdictions.
Steve holds the degrees of B.App. Sc (University of Southern Queensland), LL.B. & LL.M. (University of Adelaide), and an M.A. (Diplomacy) from Norwich University (VT).
Steve has resided in Australia, the U.S., and Canada, and his entrepreneurial approach and strength at building long term strategic alliances, coupled with his dual technical and corporate finance/law background equips him with the skill-sets necessary to bridge the gap between technical, operational, commercial, and government regulatory aspects required to create a dynamically successful, strategically focused business.
US Lithium-Ion Battery Producer
Oakridge is the poster child for the “Made in USA” movement and leads the charge in onshoring jobs and manufacturing back to America.
It manufactures hi-tech, leading edge, high quality, lithium ion batteries for high margin, niche consumer markets – golf cars, remote control cars, boats, drones and planes, home energy storage and living space power units for RVs, boats and interstate trucks, and starter motor batteries for “big boys toys” such as Harley Davidsons, jet skis, snow mobiles and boats – all cost competitive because of high quality, state of the art, automated US manufacturing techniques.
In an increasingly “unwired” world, batteries are THE recession proof product !
Energy Stock: USA Lithium Battery Manufacturer
Oakridge Global Energy Solutions is a publicly traded company, listed as OGES on the OTC, whose primary business is the manufacturing and marketing of products incorporating lithium battery technologies. The lithium batteries are constructed of lithium ion compounds that provide higher power, longer life, and are lighter weight than traditional batteries. These batteries can be employed in a broad range of commercial and government applications and incorporate a proprietary technology which enhances the safe operation of the battery.
Undervalued USA Energy Stock
Investor Highlights
Oakridge Global Energy Solutions is headquartered in Melbourne Florida. We are operating a 12000 square foot battery development, a 24,000 square foot warehouse facility, and a 50,400 square foot manufacturing facility presently employing 24 full time staff members. The manufacturing plant is equipped with state of the art fabrication and manufacturing equipment for Lithium Ion batteries. The development facility is equipped with state of the art laboratory equipment including: chemistry lab, mixing operation, characterization and testing laboratories, scanning electronic microscope, and 3D color Keyence digital microscope. We have all of the necessary test and fabrication equipment to develop battery cells and systems from raw material to final product with full testing and performance validation.
Major Objectives
Oakridge Global Energy Solutions is continuing to develop and manufacture standard off-the-shelf products for various industries as needed to meet client’s needs. The sales force will continue to interface with existing and potential clients to pursue opportunities in commercial and government markets. The development and manufacturing facilities will be optimized for the production of product as needed to meet client delivery requirements. Additional technical and administrative staff will be hired to support development and production as needed.
Investment Highlights
- Batteries made in USA using a proprietary lithium chemistry
- Lithium batteries produced are comparable in price to traditional lead-acid
batteries, but charge faster, last longer and are much lighter.
- Rapidly expanding workforce, and has been approved for nearly $9 million in
property tax breaks from Brevard County
- Confirmed orders of $19.3 million backlogged in the US
- Additional orders of $50 million in the US and Australia that are awaiting firm
delivery schedule
- Further $110 million of orders from Japan awaiting firm delivery schedule
- Primary shareholder (90 percent) is Precept Fund Management SPC
- Oakridge Global Energy Solutions owns 11,000,000 shares of Leclanché S.A., a
Swiss developer and producer of energy storage systems
- Filed for NASDAQ main board listing on July 31, 2015
Small Cap Energy Stocks To Buy
Best Stocks To Buy Now Investing News Show Money Info
Undervalued Energy Stock News
May 10, 2016:
Hear a replay of the show:
The May 10th Money Info Investing News Show features
Oil Investing in May 2016
a live interview with
Tim Connolly of Texas Gulf Oil
and
a live interview with
The May 10th show features
USA Lithium-Ion Battery Manufacturing Company
Energy Stock News
live interview with:
Oakridge Global Energy Solutions:
The Only “Made in the USA” Lithium-Ion Battery
Steve Barber, Executive Chairman & CEO
Stock Symbol: OGES
See Corporate Site: OakG.net
See Investors Information Page with stock quotes
See Energy Stock Investors Information Report
Tim Connolly of Texas Gulf Oil
Tim discusses Oil Investing in May 2016 including where to invest in Texas oil projects, oil price increase turn-around time frame and exciting opportunities created by oil price downturn.
About Tim Connolly
Tim is the Chairman, CEO, and founder of Texas Gulf Oil & Gas. Mr. Connolly is also the Managing Director and Founder of Corporate Strategies LLC, a private merchant banking firm based in Houston, Texas since 1984. Corporate Strategies portfolio companies have included interests in energy, technology, software development, defense electronics manufacturing, international nutritional products manufacturing and distribution, mobile device application development and other market segments, domestically and internationally.
Mr. Connolly has personally completed over $1 billion in transactions as principal, broker or adviser to banks, hedge funds, and investment partnerships both domestically and overseas.
USA Battery Manufacturing Stock
The May 10th show features
USA Lithium-Ion Battery Manufacturing Company
Energy Stock News
live interview with:
Oakridge Global Energy Solutions:
The Only “Made in the USA” Lithium-Ion Battery
Steve Barber, Executive Chairman & CEO
Stock Symbol: OGES
See Corporate Site: OakG.net
See Investors Information Page with stock quotes
See Energy Stock Investors Information Report
Oakridge Global Energy Solutions, Inc. is an integrated, “made in USA”, energy storage solutions company that uses state-of-the-art technology to focus on making and developing advanced, high-quality cells, batteries, and power systems.
Their energy solutions are used in consumer, government, industrial, and military applications.
The core business is in the design, development, and manufacturing of small to large format lithium ion cells, batteries, and battery systems.
Oakridge’s strategy is to simultaneously deliver innovation and build an industrial scale platform that includes multiple lithium ion technologies and form factors that are optimized to address three target markets: stationary and grid storage; motive applications including fleet vehicles, EV and HEV; and specialty applications including Military, Aerospace, Marine, Industrial, Scientific and Telecom backup.
Oakridge’s technology team is strongly engineering driven, with core capabilities in materials, product design, process control, manufacturing technology, quality and safety.
Steve Barber: Chief Executive Officer
Steve Barber has over 30 years of experience in the international business sector with dual qualifications in science and law, specializing in international corporate finance, mergers, and acquisitions, asset acquisitions, corporate restructuring, offshore financing structures and the creation of new ventures, as well as government regulatory matters and counterterrorism risk management (especially terrorism financing restructures) in a range of international jurisdictions.
Steve holds the degrees of B.App. Sc (University of Southern Queensland), LL.B. & LL.M. (University of Adelaide), and an M.A. (Diplomacy) from Norwich University (VT).
Steve has resided in Australia, the U.S., and Canada, and his entrepreneurial approach and strength at building long term strategic alliances, coupled with his dual technical and corporate finance/law background equips him with the skill-sets necessary to bridge the gap between technical, operational, commercial, and government regulatory aspects required to create a dynamically successful, strategically focused business.
US Lithium-Ion Battery Producer
Oakridge is the poster child for the “Made in USA” movement and leads the charge in onshoring jobs and manufacturing back to America.
It manufactures hi-tech, leading edge, high quality, lithium ion batteries for high margin, niche consumer markets – golf cars, remote control cars, boats, drones and planes, home energy storage and living space power units for RVs, boats and interstate trucks, and starter motor batteries for “big boys toys” such as Harley Davidsons, jet skis, snow mobiles and boats – all cost competitive because of high quality, state of the art, automated US manufacturing techniques.
In an increasingly “unwired” world, batteries are THE recession proof product !
Energy Stock: USA Lithium Battery Manufacturer
Oakridge Global Energy Solutions is a publicly traded company, listed as OGES on the OTC, whose primary business is the manufacturing and marketing of products incorporating lithium battery technologies. The lithium batteries are constructed of lithium ion compounds that provide higher power, longer life, and are lighter weight than traditional batteries. These batteries can be employed in a broad range of commercial and government applications and incorporate a proprietary technology which enhances the safe operation of the battery.
US Energy Stock Investor Highlights
Oakridge Global Energy Solutions is headquartered in Melbourne Florida. We are operating a 12000 square foot battery development, a 24,000 square foot warehouse facility, and a 50,400 square foot manufacturing facility presently employing 24 full time staff members. The manufacturing plant is equipped with state of the art fabrication and manufacturing equipment for Lithium Ion batteries. The development facility is equipped with state of the art laboratory equipment including: chemistry lab, mixing operation, characterization and testing laboratories, scanning electronic microscope, and 3D color Keyence digital microscope. We have all of the necessary test and fabrication equipment to develop battery cells and systems from raw material to final product with full testing and performance validation.
Major Objectives
Oakridge Global Energy Solutions is continuing to develop and manufacture standard off-the-shelf products for various industries as needed to meet client’s needs. The sales force will continue to interface with existing and potential clients to pursue opportunities in commercial and government markets. The development and manufacturing facilities will be optimized for the production of product as needed to meet client delivery requirements. Additional technical and administrative staff will be hired to support development and production as needed.
US Battery Manufacturing Energy Stock News
Oakridge Global Energy Solutions
Investment Highlights:
- Batteries made in USA using a proprietary lithium chemistry
- Lithium batteries produced are comparable in price to traditional lead-acid
batteries, but charge faster, last longer and are much lighter.
- Rapidly expanding workforce, and has been approved for nearly $9 million in
property tax breaks from Brevard County
- Confirmed orders of $19.3 million backlogged in the US
- Additional orders of $50 million in the US and Australia that are awaiting firm
delivery schedule
- Further $110 million of orders from Japan awaiting firm delivery schedule
- Primary shareholder (90 percent) is Precept Fund Management SPC
- Oakridge Global Energy Solutions owns 11,000,000 shares of Leclanché S.A., a
Swiss developer and producer of energy storage systems
- Filed for NASDAQ main board listing on July 31, 2015
May 3, 2015 Show:
Immunotherapy Stock and
USA Battery Stock
on Money Info Investing News Show
Hear a replay of Part 1 of the Show:
Hear a replay of Steve Barber Oakridge Global Energy Solutions, Inc. interview:
Hear a replay of Gloria Herndon and Dr Jay Ellenby from Immune Therapeutics
Show features live interviews with:
Oakridge Global Energy Solutions:
The Only “Made in the USA” Lithium-Ion Battery
Steve Barber, Executive Chairman & CEO
Stock Symbol: OGES
See Corporate Site: OakG.net
See Investors Information Page with stock quotes
See Energy Stock Investors Information Report
Oakridge Global Energy Solutions, Inc. is an integrated, “made in USA”, energy storage solutions company that uses state-of-the-art technology to focus on making and developing advanced, high-quality cells, batteries, and power systems.
Their energy solutions are used in consumer, government, industrial, and military applications.
The core business is in the design, development, and manufacturing of small to large format lithium ion cells, batteries, and battery systems.
Oakridge’s strategy is to simultaneously deliver innovation and build an industrial scale platform that includes multiple lithium ion technologies and form factors that are optimized to address three target markets: stationary and grid storage; motive applications including fleet vehicles, EV and HEV; and specialty applications including Military, Aerospace, Marine, Industrial, Scientific and Telecom backup.
Oakridge’s technology team is strongly engineering driven, with core capabilities in materials, product design, process control, manufacturing technology, quality and safety.
Steve Barber: Chief Executive Officer
Steve Barber has over 30 years of experience in the international business sector with dual qualifications in science and law, specializing in international corporate finance, mergers, and acquisitions, asset acquisitions, corporate restructuring, offshore financing structures and the creation of new ventures, as well as government regulatory matters and counterterrorism risk management (especially terrorism financing restructures) in a range of international jurisdictions.
Steve holds the degrees of B.App. Sc (University of Southern Queensland), LL.B. & LL.M. (University of Adelaide), and an M.A. (Diplomacy) from Norwich University (VT).
Steve has resided in Australia, the U.S., and Canada, and his entrepreneurial approach and strength at building long term strategic alliances, coupled with his dual technical and corporate finance/law background equips him with the skill-sets necessary to bridge the gap between technical, operational, commercial, and government regulatory aspects required to create a dynamically successful, strategically focused business.
US Lithium-Ion Battery Producer
Oakridge is the poster child for the “Made in USA” movement and leads the charge in onshoring jobs and manufacturing back to America.
It manufactures hi-tech, leading edge, high quality, lithium ion batteries for high margin, niche consumer markets – golf cars, remote control cars, boats, drones and planes, home energy storage and living space power units for RVs, boats and interstate trucks, and starter motor batteries for “big boys toys” such as Harley Davidsons, jet skis, snow mobiles and boats – all cost competitive because of high quality, state of the art, automated US manufacturing techniques.
In an increasingly “unwired” world, batteries are THE recession proof product !
Small Cap Energy Stocks To Buy
AND
Undervalued Immunotherapy Stocks
The May 3, 2016 show features a live interview with:
Gloria Herndon and Dr Jay Ellenby from Immune Therapeutics
Hear a replay of Gloria Herndon and Dr Jay Ellenby from Immune Therapeutics interview:
About Immune Therapeutics Inc.
(Stock Symbol: IMUN)
Visit The Corporate Site — ImmuneTherapeutics.com
See Corporate Investors Information and stock quote page: Click Here
Immune Therapeutics is a specialty pharmaceutical company involved in the manufacturing, distribution and marketing of our novel patented therapies to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system. The Company’s technology platform is built on two different immunotherapies, Low Dose Naltrexone (LDN) and Methionine-Enkephalin (MENK).
Both therapies have been decades in the making at institutions such as the Pennsylvania State University Medical School at Hershey, University of Chicago, State University of New York, and Multiple Sclerosis Center at UCSF. These efforts were pioneered by leading immunologists: Dr. Nicholas Plotnikoff, Dr. Ronald Herberman, Dr. Bernard Bihari, Ian S. Zagon, Dr. Jill Smith, Patricia McLaughlin, and Dr. Jaquelyn McCandless.
Immune Therapeutics has spent the last two years acquiring regulatory approval in emerging and developing nations for LDN marketed under the brand name Lodonal™. Lodonal™ is a highly innovative immunotherapy for the treatment of autoimmune diseases, HIV/AIDS, opportunistic infections, cancer and a range of other serious diseases. Our proprietary Opiate and T Cell Receptor technology exploits the power of the body’s own immune system to find and kill diseased cells.
LDN (Low Dose Naltrexone)
Low Dose Naltrexone used as an immune modulator
Low Dose Naltrexone as it is known in the United States, or Lodonal as it is known internationally, has its origins in the FDA approved 50mg Naltrexone. Originally used to treat opiate dependences, the Immune Therapeutics patented treatments, which cover a wide range of indications (link to LDN patents), is currently used as an immune modulator. See Report — Click Here
Investing News Show Undervalued Immunotherapy Stocks
April 19, 2015 Show
Small Cap Stocks to Buy April 2016
April 19th Money Info Investment News show will feature live interviews with executives from
2 top undervalued small cap stocks to buy:
Medical Products Company,
RMS Medical Systems, Inc.
(Stock Symbol: REPR)
Chairman of the Board
Andy Sealfon
and
Digital advertising company,
KSIX Media Holdings, Inc.
(Stock symbol: KSIX)
Chairman and CEO,
Carter Matzinger
Hear replay of Part 1, The Opening Of The Show:
Hear replay of Part 2, the Andy Sealfon RMS Medical Systems Interview:
Hear replay of Part 3, the Carter Matzinger KSIX Media Holdings Interview:
KSIX Media Holdings, Inc.
Visit the KSIX Media Holdings Corporate Site: KSIXMedia.com
Get KSIX Stock Quotes, Trading Charts and Latest News – Click Here
Read the KSIX Stock Report
KSIX Media is a Performance-Based Digital Ad Agency
KSIX Media Mission
The KSIX Media mission is to build a full-service digital ad agency that delivers trackable and high-performance results to our clients. They seek to identify strategic acquisitions that add intellectual properties, new methodologies, IP, web assets, and human capital to our Company. This allows KSIX to better service our clients through broader and more diverse resources as well as increase profitability.
As each division is created through accretive acquisitions, KSIX is creating unparalleled shareholder value for long-term capital growth.
KSIX Media Leadership
Digital advertising company, KSIX prides itself on RESULTS.
Driving business and increasing revenue for publishers and advertisers is what they do.
KSIX understands the role of incentive, non-incentive, PPC (Pay Per Click), CPC (Cost Per Click), CPM (Cost Per Mille), email marketing, Facebook Advertising, and traditional affiliate marketing models, and creating revenue with each.
Internet Traffic and Lead Generation Services
KSIX Media Subsidiaries
KSIX Media owns the following subsidiaries:
Ksix Network – Ksix Network has been in the affiliate marketing industry since 2005, playing a lead role in the growth of the incentive CPM (cost per mille) industry.
Blvd Media Group – BMG has been monetizing the internet since 2009 by focusing on lead generation, increasing click rates and ad revenues through two proprietary products, the RewardTool and AccessTool.
Ksix Creative – Ksix Creative is an innovative multi-media digital agency specializing in ideation, copy, design, coding, and analytics.
Digitize IQ – A full-service digital lead generation agency. Digitize IQ is the largest lead generation company utilizing social media in the industry.
See More — Click Here
Digital Advertising Business Growth
KSIX Media Holdings, Inc. corporate growth and expansion plan includes acquiring companies well-positioned in niche markets with strong revenues and business models that leverage the power of affiliate marketing and targeted advertising online.
Companies on its radar are digital ad revenue generated businesses looking for an exit strategy and resources so they can focus on their core competencies while being part of a bigger company in a fast-growing niche market space
KSIX was founded on the principle that making money, having fun, and ensuring long-term success can all go hand-in-hand.
While the KSIX brand name may be new, the company has been involved in Affiliate Marketing since 2005, playing a leading role in the growth of the incentive CPA (Cost Per Action) industry and are now at the forefront of the non-incentive industry as well.
The Company’s knowledge and expertise on the Advertiser side dramatically increases revenue, while maintaining tight control over costs. Their performance-based marketing solutions drive you traffic and conversions while maintaining the Cost-Per-Action business model.
As a defacto digital ad agency, KSIX understands the role of incentive, non-incentive, PPC (Pay Per Click), CPC (Cost Per Click), CPM (Cost Per Mille), email marketing and traditional affiliate marketing models, creating revenue with each.
KSIX is a leading in Facebook ad placement and management. They deliver to customers Facebook marketing and sales strategies that generate likes, engagement and conversions, while driving down costs and increasing the amount of leads gained (likes gained).
Online advertising services offered by KSIX include:
- Lead Gen, Downloads (including Mobile)
- Mobile surveys
- Trial Offers
- CoReg
- Host & Post
- Incentive Traffic (i.e. Virtual Currency)
About Carter Matzinger – KSIX Media Holdings, Inc.
Chairman and Chief Executive Officer
Mr. Matzinger has over 17 years of diverse experience including working with many Fortune 500 companies including: The Limited, CompuServe, Goodyear Tire, and Amoco.
For the past eight years, Mr. Matzinger has worked in the field of online marketing and has specialized in building large affiliate networks. He works closely with online advertisers and advertising networks to expand the reach of profitability of the Company.
His experience in search engine optimization, list management, and pay-per-click advertising provides a vast network of relationships and industry expertise.
Mr. Matzinger is the co-founder and President of Blvd Media Group, LLC, and KSIX LLC.
Mr. Matzinger is a graduate of the University of Utah in 1997 B.A. in Business Administration.
Digital Online Advertising Stock News
KSIX Media Completes Acquisition of DigitizeIQ
Acquisition Provides KSIX Expansion Into the Mass Tort Lead Generation Market
KSIX has completed acquisition of DigitizeIQ, a mass tort lead generation company that utilizes social media.
“We’re extremely excited to complete this acquisition and have DigitizeIQ become a part of KSIX Media,” stated Matzinger. “We’re thrilled to add a leader in mass tort lead generation, which opens up a whole market for KSIX. Facebook marketing aligns with our goals perfectly as we continue to seek niche-marketing companies in the digital advertising sector. We believe that DigitizeIQ is a perfect addition to our portfolio and believe it will increase value for our shareholders.”
——————————————————–
Medical Products Company,
RMS Medical Systems, Inc.
(Stock Symbol: REPR)
Chairman of the Board
Andy Sealfon
RMS Medical Products is a U.S. manufacturer of medical devices which maintains offices and manufacturing facilities in Chester, NY. They employ 60 people. For more than three decades, the company has been a leading innovator in the medical device industry in the development and production of proprietary devices and supplies.
Principal products include the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.
Visit the corporate website: RMSMedicalProducts.com
Click Here For REPR stock quotes,
trading charts and latest news releases
See RMS Medical Investors Information Page with financials —Click here
Undervalued Small Cap Medical Stock News
Repro Med Systems, Inc. Posts Strong Revenue Growth,
Productivity Gains and Announces New Interim Chief Operating Officer
The Freedom60 has a proprietary technology
that makes it desirable for the
delivery of medications in a wide variety of therapies.
It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.
This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60.
Improves quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.
RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump, but can be used with any manufacturer’s infusion pump as well.
RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event of disasters where power is lost because it doesn’t require electricity.
The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles, which are considerably less painful when entering the skin.
STRONG GROWTH CONTINUES
REPR Annual Revenue and Profits Continue To Increase
April 5, 2016 Show
Undervalued Small Cap Telecommunications Stock
on Investing News Show
Hear replay of Part 1 of the show
Hear replay of Terry Howlett and Skinvisible, Inc. (SKVI) interview:
Hear replay of John Farlinger, and Urban Communications Inc. (UBN) interview:
The April 12th small cap stocks to buy and investing news show, Money Info, will feature:
John A. Farlinger, CEO of
Urban Communications Inc.
See Corporate Site: UrbanCom.net
Stock symbol; UBN on the TSX.V
Get quote, trading charts and latest news
See Corporate Power Point Presentation
Urban Communications Inc. (TSX VENTURE: UBN) is a telecommunications company providing a full suite of Internet, voice, video and broadband application products over its 200 km. state-of-the-art carrier grade fibre optic network in Metro Vancouver and Victoria to commercial, residential and public sector customers. Urban has recently launched high-speed Internet service to residential and commercial subscribers on its network at 1,000 Mbps (1 Gbps).
1-GIG ULTRAFAST INTERNET SERVICE
Voice Solutions
Urbancom.net provides a full range of VoIP solutions from a single line to full hosted PBX for enterprise and government customers
Powerful Business Solutions
Our network of fixed wireless microwave towers and fiber optic network allows us to deliver a secure and ultra-fast network to our business customers.
Wireless Solutions
Urbancom.net provides carrier-grade licensed microwave solutions, connecting you to high speed Ethernet with 99.999%
April 12, 2016 Part 2:
Hear replay of Part 1 of the show
Hear replay of Terry Howlett and Skinvisible, Inc. (SKVI) interview:
Hear replay of John Farlinger, and Urban Communications Inc. (UBN) interview:
Skin Care and Sunscreen Product Stocks
on Investment News Show
The April 12th small cap stocks to buy and investing news show, Money Info, features:
Terry Howlett,
President & CEO of
Skinvisible, Inc.
Stock Symbol: SKVI
SKINVISIBLE PHARMACEUTICALS, INC.
See Skinvisible Corporate Site — Skinvisible.com Click Here
Get Skinvisible (SKVI) stock quote, trading chart and latest news from YAHOO finance —Click Here
Skinvisible Pharmaceuticals is a research-and-development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time resisting both wash off and perspiration along with controlling the release of actives and reducing skin irritation. Skinvisible’s value also lies in its ability to continually generate new IP on topical products formulated with Invisicare. www.skinvisible.com, www.invisicare.com
Skin and Sunscreen Products Stocks
Skinvisible’s mission is to develop innovative technology and superior topical polymer delivery vehicles designed to significantly enhance product performance for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic and skincare products.
It is Skinvisible’s intention to direct its ongoing energies and resources towards the following objectives:
- To capitalize on licensing opportunities for its Invisicare technology and formulated products to established pharmaceutical, medical, cosmetic, skincare and consumer goods manufacturers.
- To develop new polymer delivery vehicles designed to create or enhance formulated products for existing and new customers for a variety of applications.
- To enter into strategic relationships and attract alliances to expand research, development and collaborative product investigations for its patented polymer delivery vehicles and formulations.
- To increase on-going revenues and profitability from current licensees.
- To maximize shareholder value.
Terry Howlett — President & Chief Executive Officer
Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company’s development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett’s diversified background includes senior management, marketing, and sales positions with both established and start-up companies.
Sunscreen Products Stock NEWS
Skinvisible’s Kintari Launches New Addition to Product Line
Kintari’s Skincare Line Expands
April 6, 2016 Skinvisible Inc., (SKVI) through its wholly-owned subsidiary Kintari USA Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official expansion of its product line to include Kintari’s long-lasting Hand & Body Lotion.
Kintari’s product line now consists of four skincare products, all uniquely formulated utilizing our patented Invisicare® skin delivery technology and developed by scientists from Skinvisible Pharmaceuticals, Inc.
Skinvisible Expands Its Patent Portfolio with Comprehensive Acne Patent Adapalene, Retinoic Acid, Clindamycin and OTC Actives Now with IP Protection
Skinvisible Pharmaceuticals, Inc. (SKVI) a pharmaceutical research and development company with its proprietary skin delivery technology Invisicare(R), today announced that it has expanded its patent portfolio with a new patent granted by the United States Patent and Trademark Office entitled, “ACNE TREATMENT COMPOSITION AND METHODS FOR USING.”
“This patent is an important component of Skinvisible’s comprehensive intellectual property portfolio which includes sixteen patents that provide protection in the US and major international markets up to the year 2030. The granting of this patent recognizes the unique qualities of our Invisicare delivery technology. With the acne market generating over $5 billion in the U.S. last year, this new patent further enhances the value of our pipeline of products,” said Mr. Terry Howlett, President. “We are actively seeking a partner to license and advance the clinical development of our acne formulations and other prescription dermatology products.”
Skinvisible’s Kintari Revolutionizes the Sunscreen Market Skinbrella(R) Officially Launched
Skinvisible Inc., through its wholly-owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official launch of Skinbrella(R), a patented sunscreen like no other. Skinbrella meets or exceeds all FDA requirements for a broad-spectrum, 80 minute water-resistant sunscreen.
Small Cap Stocks To Buy Investment News Show Replays
Money Info Show
Replay Archives
Hear Replays of
December 2015 to October 2015 Shows
Hear Replays of
December 2015 to October 2015 Shows
Click Here
Hear Replays of
September 2015 to June 2015 Shows
Click Here
Hear Replays of
June 2015 to April 2015 Shows
Click Here
The Princeton Research Money Info Show features
where to invest now,
stock market, business, economy and
financial investment news.
Stock Options Trading Alerts Update:
In order to make more investors aware of the exceptional gains we are producing with our Options Trading Alerts Service we are offering (for a very limited time) free sample trade alerts and sample issues of the Market Strategies Newsletter.
See http://www.princetonresearch.com/options-trading.htm to get in today.